Clinical trials
Completed Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5,501 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 48 |
| 2001 | 56 |
| 2002 | 78 |
| 2003 | 103 |
| 2004 | 146 |
| 2005 | 182 |
| 2006 | 235 |
| 2007 | 248 |
| 2008 | 221 |
| 2009 | 237 |
| 2010 | 258 |
| 2011 | 253 |
| 2012 | 266 |
| 2013 | 258 |
| 2014 | 234 |
| 2015 | 282 |
| 2016 | 278 |
| 2017 | 260 |
| 2018 | 274 |
| 2019 | 271 |
| 2020 | 262 |
| 2021 | 269 |
| 2022 | 214 |
| 2023 | 187 |
| 2024 | 123 |
| 2025 | 60 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5,501 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 187 |
| GlaxoSmithKline | 94 |
| Novartis Pharmaceuticals | 81 |
| AstraZeneca | 71 |
| M.D. Anderson Cancer Center | 70 |
| Bayer | 67 |
| Amgen | 60 |
| Eli Lilly and Company | 58 |
| Boehringer Ingelheim | 57 |
| Memorial Sloan Kettering Cancer Center | 55 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 5,501 |
| Breast Neoplasms | 393 |
| Neoplasm Metastasis | 315 |
| Prostatic Neoplasms | 218 |
| Carcinoma, Non-Small-Cell Lung | 211 |
| Colorectal Neoplasms | 199 |
| Lung Neoplasms | 178 |
| Pain | 172 |
| Melanoma | 151 |
| Ovarian Neoplasms | 147 |
Trials
Showing 76 to 100 of 5,501. Each trial links to its page on Pharma Observatory.
5,401 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.